18-78992436-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_171999.4(SALL3):āc.445C>Gā(p.Pro149Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000729 in 1,371,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000060 ( 0 hom., cov: 33)
Exomes š: 0.000075 ( 0 hom. )
Consequence
SALL3
NM_171999.4 missense
NM_171999.4 missense
Scores
2
17
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
SALL3 (HGNC:10527): (spalt like transcription factor 3) This gene encodes a sal-like C2H2-type zinc-finger protein, and belongs to a family of evolutionarily conserved genes found in species as diverse as Drosophila, C. elegans, and vertebrates. Mutations in some of these genes are associated with congenital disorders in human, suggesting their importance in embryonic development. This protein binds to DNA methyltransferase 3 alpha (DNMT3A), and reduces DNMT3A-mediated CpG island methylation. It is suggested that silencing of this gene, resulting in acceleration of DNA methylation, may have a role in oncogenesis. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04984051).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SALL3 | NM_171999.4 | c.445C>G | p.Pro149Ala | missense_variant | 2/3 | ENST00000537592.7 | NP_741996.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SALL3 | ENST00000537592.7 | c.445C>G | p.Pro149Ala | missense_variant | 2/3 | 5 | NM_171999.4 | ENSP00000441823 | P1 | |
SALL3 | ENST00000575389.6 | c.445C>G | p.Pro149Ala | missense_variant | 2/4 | 5 | ENSP00000458360 | |||
SALL3 | ENST00000536229.7 | c.46C>G | p.Pro16Ala | missense_variant | 1/3 | 3 | ENSP00000439975 |
Frequencies
GnomAD3 genomes AF: 0.0000600 AC: 9AN: 149962Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
9
AN:
149962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000476 AC: 1AN: 20988Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 13116
GnomAD3 exomes
AF:
AC:
1
AN:
20988
Hom.:
AF XY:
AC XY:
0
AN XY:
13116
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000745 AC: 91AN: 1221268Hom.: 0 Cov.: 30 AF XY: 0.0000634 AC XY: 38AN XY: 599098
GnomAD4 exome
AF:
AC:
91
AN:
1221268
Hom.:
Cov.:
30
AF XY:
AC XY:
38
AN XY:
599098
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000600 AC: 9AN: 149962Hom.: 0 Cov.: 33 AF XY: 0.0000547 AC XY: 4AN XY: 73160
GnomAD4 genome
AF:
AC:
9
AN:
149962
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
73160
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | The c.445C>G (p.P149A) alteration is located in exon 2 (coding exon 2) of the SALL3 gene. This alteration results from a C to G substitution at nucleotide position 445, causing the proline (P) at amino acid position 149 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.
REVEL
Benign
Sift
Benign
.;T;.
Sift4G
Benign
T;T;T
Polyphen
0.0070
.;B;.
Vest4
MutPred
Loss of glycosylation at P149 (P = 0.0065);Loss of glycosylation at P149 (P = 0.0065);.;
MVP
MPC
0.38
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at